WHO ICTRP trial
The pharmacokinetic study of Cefotaxime Sodium and Tazobactam Sodium (6:1) for…
ChiCTR1900023961 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900023961 |
|---|---|
| Public title | The pharmacokinetic study of Cefotaxime Sodium and Tazobactam Sodium (6:1) for injection in human |
| Scientific title | The pharmacokinetic study of Cefotaxime Sodium and Tazobactam Sodium (6:1) for injection in human |
| Primary sponsor | Center for Clinical Pharmacology, the Third Xiangya Hospital, Central South University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Respiratory infections, urinary tract infections, meningitis, sepsis, abdominal infections, pelvic infections, skin and soft tissue infections, reproductive tract infections, bone and joint infections |
| Interventions | Group A of single dose:cefotaxime sodium and tazobactam sodium(T)1g-T2g-cefotaxime sodium(R)4g-T4g;Group B of single dose:T2g-T4g-T1g-R4g;Group C of single dose:T4g-R4g-T2g-T1g;Group D of single dose:R4g-T1g-T4g-T2g;Multiple dose group:T3g… |
| Registration date | Jun 19, 2019 |
| Target size | Group A of single dose:4;Group B of single dose:4;Group C of single dose:4;Group… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: